Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiovascular mortality in transient ischemic attacks

S Heyden, G Heiss, A Heyman

    Stroke
    |May 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Corrigendum to "International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer": [Annals of Oncology 33 (2022) 57-66].

    Annals of oncology : official journal of the European Society for Medical Oncology·2022
    Same author

    International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2021
    Same author

    Statistical controversies in clinical research: futility analyses in oncology-lessons on potential pitfalls from a randomized controlled trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017
    Same author

    Efficacy and safety of maintenance pemetrexed in patients with advanced nonsquamous non-small cell lung cancer following pemetrexed plus cisplatin induction treatment: A cross-trial comparison of two phase III trials.

    Lung cancer (Amsterdam, Netherlands)·2014
    Same author

    CEREBROVASCULAR DISEASES. ADVANCES IN CLINICAL DIAGNOSIS SINCE 1950.

    A listing of research in the cardiovascular field·2014
    Same author

    Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial).

    Annals of oncology : official journal of the European Society for Medical Oncology·2013
    Same journal

    Management of Patients at Risk of Ischemic Stroke With Left Ventricular Systolic Dysfunction in the Absence of Intracardiac Thrombus: A Scientific Statement From the American Heart Association.

    Stroke·2026
    Same journal

    Update on Rehabilitation After Stroke: Global Changes and the Continued Importance of Therapy Intensity, Dose, and Timing.

    Stroke·2026
    Same journal

    ENTF Neuromodulation Yields Reduced Disability After Stroke: An Individual Participant-Level Data Meta-Analysis.

    Stroke·2026
    Same journal

    Menopause and Its Implications for Stroke in Women.

    Stroke·2026
    Same journal

    Physician Approaches to Determining Goals of Stroke Care for Patients Living With Disability or Dementia: Results from the SEED Mixed-Methods Study.

    Stroke·2026
    Same journal

    Aspirin for Stroke Primary Prevention: A Step Toward Genetic-Driven Personalized Medicine.

    Stroke·2026
    See all related articles

    Mortality risk is elevated in individuals with definite Transient Ischemic Attack (TIA). Traditional risk factors like heart disease, hypertension, and diabetes do not explain this increased mortality over a 10-year follow-up period.

    Area of Science:

    • Epidemiology
    • Public Health
    • Neurology

    Background:

    • Transient Ischemic Attack (TIA) is a critical warning sign for cerebrovascular events.
    • Understanding long-term mortality risk following a TIA diagnosis is crucial for patient management and public health strategies.

    Purpose of the Study:

    • To analyze the mortality rates in individuals diagnosed with definite TIA.
    • To investigate whether common cardiovascular and metabolic risk factors explain the observed excess mortality.

    Main Methods:

    • Epidemiologic survey conducted in a biracial Southern community.
    • Statistical analysis of mortality data over a 10-year follow-up period.
    • Assessment of known risk factors including heart disease, hypertension, and diabetes.

    Related Experiment Videos

    Main Results:

    • An excess of deaths was observed in the TIA cohort over the 10-year follow-up.
    • Conventional risk factors such as heart disease, hypertension, and diabetes did not account for the elevated mortality.
    • The findings suggest unidentified factors contributing to increased mortality post-TIA.

    Conclusions:

    • Individuals with definite TIA face a higher mortality risk.
    • The underlying causes for this excess mortality remain unclear and warrant further investigation.
    • Future research should explore novel risk factors and biological mechanisms associated with TIA prognosis.